Disclosures
All the authors declare that there are no conflicts of interest.
References
1. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qi A, Vorderbrugge S, Kerr CR. Atrial flutter in patients treated for atrial fibrillation with propafenone. The American journal of cardiology.1990;66(7):755-757.
2. London F, Howell M. Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis. American heart journal.1954;48(1):152-156.
3. Robertson CE, Miller HC. Extreme tachycardia complicating the use of disopyramide in atrial flutter. British heart journal.1980;44(5):602-603.
4. Crijns HJ, van Gelder IC, Lie KI. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. The American journal of cardiology. 1988;62(17):1303-1306.
5. Feld GK, Chen PS, Nicod P, Fleck RP, Meyer D. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. The American journal of cardiology. 1990;66(3):378-383.
6. Aranda JM, Moleiro F, Castellanos A, Befeler B. Electrophysiologic studies in a patient with atrial flutter and 1:1 atrioventricular conduction. Chest. 1975;68(2):200-204.
7. Ito K, Iwasaki YK, Fujimoto Y, et al. Massive Right Atrial Thrombus Formation Followed by an Atrial Flutter with 1:1 Atrioventricular Conduction in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy. Internal medicine (Tokyo, Japan).2016;55(16):2213-2217.
8. Finkelstein D, Gold H, Bellet S. Atrial flutter with 1:1 A-V conduction; report of six cases. The American journal of medicine. 1956;20(1):65-76.
9. Brembilla-Perrot B, Houriez P, Beurrier D, Claudon O, Terrier de la Chaise A, Louis P. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias. International journal of cardiology.2001;80(1):7-15.
10. Brembilla-Perrot B, Laporte F, Sellal JM, et al. 1:1 atrial-flutter. Prevalence and clinical characteristics. International journal of cardiology. 2013;168(4):3287-3290.
11. Kawabata M, Hirao K, Higuchi K, et al. Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.2008;10(3):284-288.
12. Wang Z, Page P, Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circulation research.1992;71(2):271-287.
13. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation. 1993;88(3):1030-1044.
14. Turitto G, Akhrass P, Leonardi M, Saponieri C, Sette A, El-Sherif N. Atrial flutter with spontaneous 1:1 atrioventricular conduction in adults: an uncommon but frequently missed cause for syncope/presyncope.Pacing and clinical electrophysiology : PACE. 2009;32(1):82-90.